Skip to main content

Table 1 Correlation between KDM5B expression and clinicopathological features in HCC

From: Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27

Clinicopathological features

n

KDM5B

High expression

(≥Median)

Low expression

(<Median)

P-value

Gender

    

 Male

65

34

31

0.6753

 Female

35

16

19

 

Age (years)

    

  ≥ 50

60

32

28

0.5406

  < 50

40

18

22

 

Tumor size (cm)

    

  ≥ 5

55

36

19

0.0012**

  < 5

45

14

31

 

Tumor number

    

 Solitary

62

33

29

0.5368

 Multiple

38

17

21

 

HBsAg

    

 Positive

76

40

36

0.4829

 Negative

24

10

14

 

HCV

    

 Positive

11

8

3

0.1997

 Negative

89

42

47

 

Cirrhosis

    

 Positive

82

43

39

0.4356

 Negative

18

7

11

 

ALT (U/L)

    

  ≥ 45

46

26

20

0.3158

  < 45

54

24

30

 

AFP (ng/ml)

    

  ≥ 20

57

31

26

0.4193

  < 20

43

19

24

 

TNM stage

    

 I + II

56

21

35

0.0085**

 III + IV

44

29

15

 

Edmondson grade

    

 I + II

59

23

36

0.0142*

 III + IV

41

27

14

 
  1. The median expression level of KDM5B was used as the cut off
  2. *P < 0.05
  3. **P < 0.01 between the two groups